Skip to main content

Cullinan Oncology Inc

For the period ended Dec 31, 2023. Filed Mar 14, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 14, 2024

CGEM$11.23-4.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 14. Principal Accountant Fees and Services

We incurred the following fees from KPMG LLP for the audit of the consolidated financial statements and for other services provided during 2023 and 2022.

Fee Category20232022
Audit fees(1)$836,166$702,500
Audit-related fees(2)——
Tax fees(3)393,638307,420
All other fees(4)——
Total Fees$1,229,804$1,009,920

(1)

Audit fees consist of fees for the professional services rendered by KPMG for the audit of our annual financial statements, the financial statements included in our Form 10-Qs, the review of our interim financial statements, comfort letters and consents.

(2)

There were no audit-related fees for 2023 and 2022.

(3)

Tax fees consist of fees for tax compliance, tax advice and tax planning.

(4)

There were no other fees for 2023 and 2022.

Audit Committee Pre-approval Policy and Procedures

Our audit committee has adopted policies and procedures relating to the approval of all audit and non-audit services that are to be performed by our independent registered public accounting firm. This policy provides that we will not engage our independent registered public accounting firm to render audit or non-audit services unless the service is specifically approved in advance by our audit committee or the engagement is entered into pursuant to the pre-approval procedure described below.

From time to time, our audit committee may pre-approve specified types of services that are expected to be provided to us by our independent registered public accounting firm during the next 12 months. Any such pre-approval details the particular service or type of services to be provided and is also generally subject to a maximum dollar amount.

During 2023 and 2022, no services were provided to us by KPMG LLP other than in accordance with the pre-approval policies and procedures described above.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.